Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis

Clinical trial NCT00332696 · COMPLETED

Trial details

NCT number: NCT00332696
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Peritoneal Neoplasms Intestinal Obstruction Carcinomatosis

Start date: 2005-09-01
Primary completion: 2008-09-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.